Why PFAS is no longer just a treatment problem

When organizations first began addressing PFAS, much of the discussion centered on risk assessment, detection, treatment and regulatory compliance. While those themes still remain central to PFAS management, the conversation has broadened. PFAS is influencing investment decisions, long term risk mitigation, procurement strategies and long-term business planning.

At our recent PFAS Forum in Toronto, leaders from industry, government and the environmental sector came together to discuss the current challenges and opportunities for PFAS. Through audience polling and discussion, three clear signals emerged. Together, they offer a snapshot of where participants see the greatest opportunities and pressures in the years ahead.

One of the clearest findings from the forum polling was the industry's preference for integrated treatment approaches. In a multiple-response poll, 83 percent of participants selected integrated treatment trains combining removal and destruction technologies. Adsorption technologies were selected by 33 percent, while 17 percent selected standalone destruction technologies.

The responses point to a practical reality: long-term PFAS control may require technologies to work together and a holistic PFAS treatment strategy is needed. Organizations need to evaluate treatment solutions against site conditions, performance objectives, residual management requirements and regulatory expectations.

That perspective aligned with forum discussions around treatment validation and technology selection. Participants explored the challenges associated with demonstrating destruction performance and understanding what happens to PFAS compounds during treatment. Conversations also highlighted the importance of robust measurement strategies and clearly defined success criteria when evaluating treatment options.

Rather than searching for a single breakthrough technology, many organizations appear to be building treatment trains strategies that draw on the strengths of multiple approaches.

Poll responses showed that PFAS considerations now extend well beyond environmental management teams. Property transactions received the most selections when participants were asked which business decisions PFAS-related risks had affected. Insurance coverage, brand strategy and supplier contracts also featured prominently. The responses place PFAS within a wider set of commercial and governance considerations. PFAS is increasingly becoming part of due diligence activities, risk assessments and governance discussions.

This forum discussion reinforced this trend. Participants described how liability concerns and uncertainty surrounding measurement, testing and future obligations can influence decision-making. In many cases, organizations are weighing not only technical performance but also long-term business implications/risk when evaluating PFAS management options. 

For business leaders, this creates a different challenge. Success is no longer defined solely by managing contamination. It also involves understanding how PFAS may affect transactions, stakeholder confidence, long-term liabilities and future investment decisions.

When participants looked ahead five years, the strongest response did not center on treatment technologies. 40 percent of attendees selected source reduction and product substitution as the area where the PFAS industry could see the greatest progress over the next five years. PFAS destruction technologies followed at 30 percent, while monitoring and analytics and regulatory frameworks each received 15 percent.

The responses point to upstream treatment and remediation as essential. Organizations are also examining how product choices, supply chains and practical alternatives could reduce future PFAS challenges. 

Forum presentations identified source control as an operational priority. Managing PFAS before it enters the environment can limit the volume that later requires treatment and may help organizations manage operational complexity and future liabilities.

The forum findings point to a practical shift in PFAS management. Treatment decisions need to account for site conditions, residuals, measurement requirements and changing regulatory expectations. PFAS risk is also influencing property transactions, procurement and investment planning.

Organizations can respond by connecting PFAS data with business decisions. That starts with clear treatment objectives and a closer examination of PFAS sources across products and supply chains. Organizations should also document how technical choices affect long-term risk. The next phase of PFAS management calls for a decision process that can respond as evidence and regulatory expectations change.

Whether you're evaluating treatment technologies, assessing liabilities, or identifying opportunities to reduce PFAS at the source, our team can help. Contact us to explore solutions that support informed decisions today while preparing for tomorrow's challenges.